Zinc ligand-disrupted recombinant human Endostatin: Potent inhibition of tumor growth, safety and pharmacokinetic profile

Angiogenesis

Volumn 3, Issue 1, 1999, Pages 41-51

  Sim, B Kim Lee ^a   Fogler, William E ^a   Zhou, Xin Hua ^a   Liang, Hong ^a   Madsen, John W ^a   Luu, Kieu ^a   O'Reilly, Michael S ^b   Tomaszewski, Joseph E ^c   Fortier, Anne H ^a  

^a ENTREMED INC   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

Endostatin; Inhibition of angiogenesis; Tumor growth inhibition

Indexed keywords

MACACA FASCICULARIS; MURINAE;

EID: 0002158323     PISSN: 09696970     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1009058931769     Document Type: Article

References (12)

1. Folkman J. Tumor angiogenesis: therapeutic implications. N Engl J Med 1971; 285: 1182-6.
2. O'Reilly M, Boehm T, Shing Y et al. Endostatin: An endogenous inhibitor of angiogenesis and tumor growth. Cell 1997; 88: 277-85.
3. Boehm T, Folkman J, Browder T et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature 1997; 390: 404-5.
4. Dhanabal M, Ramachandran R, Volk R et al. Endostatin: Yeast production, mutants, and antitumor effect in renal cell carcinoma. Cancer Res 1999; 59: 189-97.
5. Hohenester E, Sasaki T, Olsen B et al. Crystal structure of the angiogenesis inhibitor endostatin at 1.5 A resolution. EMBO 1998; 17: 1656-64.
6. Ding Y, Javaherian K, Lo K et al. Zinc-dependent dimers observed in crystals of human endostatin. Proc Natl Acad Sci 1998; 98: 10443-8.
7. Boehm T, O'Reilly M, Keough K et al. Zinc-binding of endostatin is essential for its antiangiogenic activity. Biochem Biophys Res Commun 1998; 252: 190-4.
8. Oh S, Warman M, Seldin M et al. Cloning of cDNA and genomic DNA encoding human type XVIII collagen and localization of the α1 (XVIII) collagen gene to mouse chromosome 10 and human chromosome 21. Genomics 1994; 19: 494-9.
9. Chang Y, Zajicek J, Castellino F. Role of tryptophan-63 of the kringle 2 domain of tissue-type plasminogen activator in its thermal stability, folding, and ligand binding properties. Biochemistry 1997; 36: 7652-63.
10. Hart IR. The selection and characterization of an invasive variant of the B16 melanoma. Am J Path 1979; 97: 587-600.
11. Sato Y, Rifkin D. Autocrine activities of basic fibroblast growth factor: Regulation of endothelial cell movement, plasminogen activator synthesis, and DNA synthesis. J Cell Biol 1988; 107: 1199-205.
12. Sim K, O'Reilly M, Liang H et al. A recombinant human angiostatin protein inhibits experimental primary and metastatic cancer. Cancer Res 1997; 57: 1329-34.